Sigma-Aldrich Investor Home
News Releases
Financial Reports
2008 Proxy Statement
SEC Filings
Fundamentals
Calls/Webcast Archive
Stock Quote
Stock Chart
Dividend History
Analyst Coverage
Earnings/Estimates
Calendar
E-mail Alerts
Request Information
Officers & Directors
Directors' Business Ethics Policy
Business Conduct Policy
Whistleblower Policy
Compensation Committee Charter
Corporate Governance Committee Charter
Audit Committee Charter
Articles of Incorporation
Bylaws
   
Investor Relations Home
 
Corporate Profile
Sigma-Aldrich is a leading Life Science and High Technology company. Our biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing. We have customers in life science companies, university and government institutions, hospitals and in industry. Sigma-Aldrich operates in 36 countries and has over 7,900 employees providing excellent service worldwide.
More >>
Sigma-Aldrich Acquires Seppro(R) Depletion Technology From GenWay Biotech - 01/06/09
Sigma-Aldrich now offering antibody-based depletion columns and new catalog of IgY antibodies to proteomics research community ST. LOUIS, Mo., Jan. 6 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL) has expanded its proteo... More >>
ASM International N.V. and SAFC Hitech(TM) Sign Certified Manufacturer and Partnership Agreement - 01/06/09
Deal Paves Way For Use of ALD Ultra High-k Insulators; Marks Transition to 3x nm Memory Nodes ALMERE, The Netherlands and ST. LOUIS, Jan. 6 /PRNewswire-FirstCall/ -- ASM International N.V. (Nasdaq: ASMI; Euronext Exchange in Amsterdam: ASM... More >>
CompoZr(TM) Technology Recognized By The Scientist Magazine - 12/23/08
Gene Editing Technology by Sigma-Aldrich included in Top 10 Innovations of 2008 ST. LOUIS, MO , December 23, 2008 -- Sigma-Aldrich's (NASDAQ: SIAL) CompoZr Zinc Finger Nuclease (ZFN) technology has been recognized as one of the Top 10 Innovation... More >>
Sigma-Aldrich Signs Agreement With SouthWest NanoTechnologies to Distribute SWeNT(R) Single-Wall Carbon Nanotubes - 12/03/08
Potential applications include automotive, aeronautics, electronics, displays, energy and healthcare markets ST. LOUIS, Dec. 3 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL) and SouthWest NanoTechnologies Inc. (... More >>
Aldrich(R) Releases Materials Science Catalog That Includes Products to Advance Sustainable Energy and Nanotechnology Research - 11/26/08
ST. LOUIS, Nov. 26 /PRNewswire-FirstCall/ -- Aldrich, a division of Sigma-Aldrich (Nasdaq: SIAL), has released its new "materials by application" Materials Science catalog. The catalog features more than 4,000 products for research in Alterna... More >>
Sigma-Aldrich Enters Into Research Collaboration Program With D-Finitive Cell Technologies, Inc., to Develop Research Tools for Regenerative Medicine - 11/25/08
ST. LOUIS, Nov. 25 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL) announced today it has entered into a research collaboration program with D-Finitive Cell Technologies, Inc. This collaboration is expected to support the development a... More >>
Sigma-Aldrich to Present at the 19th Annual Citi Chemicals Conference Tuesday, December 2, 2008 - 11/25/08
ST. LOUIS, Nov. 25 /PRNewswire-FirstCall/ -- Sigma-Aldrich Corporation (Nasdaq: SIAL) will be presenting at the 19th Annual Citi Chemicals Conference on Tuesday, December 2nd at 3:15 PM ET in New York. Interested parties may listen via live au... More >>
Sigma-Aldrich Introduces MISSION(R) In VIVO QUALITY and iScale Oligos(TM) siRNA, a Superior Quality siRNA Designed for RNAi Research in Animal Models - 11/20/08
ST. LOUIS, Nov. 20 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL) announced today the global release of MISSION(R) In VIVO QUALITY and iScale Oligos(TM) siRNA. MISSION(R) In VIVO QUALITY and iScale Oligos(TM) siRNA are expected to allo... More >>
Sigma-Aldrich Enters Distribution Agreement With AlphaGenix, Inc. - 11/13/08
Sigma-Aldrich to Carry Key Products for Regenerative Medicine and Stem Cell Biology Research ST. LOUIS, Nov. 13 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL) today announced a distribution agreement wit... More >>
Sigma-Aldrich (Nasdaq: SIAL) Declares Quarterly Dividend - 11/11/08
ST. LOUIS, Nov. 11 /PRNewswire-FirstCall/ -- At the Board of Directors meeting held today, the Directors declared a quarterly cash dividend of $.13 per share. The dividend is payable on December 15, 2008 to shareholders of record on December 1... More >>
Exchange
NASDAQ GS
Listed Security
SIAL Common Stock
Transfer Agent
Registered Shareholder Contact Information
American Stock Transfer & Trust Company
Shareholder Services Department
6201 15th Street
Brooklyn, NY 11219
Toll Free: (800) 937-5449
Local & International: (718) 921-8124
Email: investors@amstock.com
Web site: www.amstock.com
Copyright © 2008 MarketWatch, Inc. All rights reserved. Please see our Terms of Use.
Designed and powered by Dow Jones Client Solutions
Intraday data provided by Interactive Data Real Time Services and subject to the Terms of Use.
Intraday data is at least 20-minutes delayed. All times are ET.
Historical and current end-of-day data provided by Interactive Data Pricing and Reference Data.
   

What's New:

Download Documentation 2007 Annual Report

Most Recent Presentations:

Useful Links:


NOTE: The stock price performance
shown on the quote above is not
necessarily indicative of future
price performance.

Print Page Print Page
E-mail Page E-mail Page
RSS Feeds RSS Feeds
E-mail Alerts E-mail Alerts
IR Contacts IR Contacts
Financial Tear Sheet Financial Tear Sheet
 

© 2006 Sigma-Aldrich Co. Reproduction forbidden without permission.
Sigma-Aldrich brand products are sold exclusively through Sigma-Aldrich, Inc. Best viewed in IE5 or higher